164 related articles for article (PubMed ID: 31534204)
1. Recurrent KRAS mutations in papillary renal neoplasm with reverse polarity.
Al-Obaidy KI; Eble JN; Nassiri M; Cheng L; Eldomery MK; Williamson SR; Sakr WA; Gupta N; Hassan O; Idrees MT; Grignon DJ
Mod Pathol; 2020 Jun; 33(6):1157-1164. PubMed ID: 31534204
[TBL] [Abstract][Full Text] [Related]
2. Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma.
Kim SS; Cho YM; Kim GH; Kee KH; Kim HS; Kim KM; Kim JH; Choi C
Mod Pathol; 2020 Apr; 33(4):690-699. PubMed ID: 31953522
[TBL] [Abstract][Full Text] [Related]
3. Papillary Renal Neoplasm With Reverse Polarity: A Morphologic, Immunohistochemical, and Molecular Study.
Al-Obaidy KI; Eble JN; Cheng L; Williamson SR; Sakr WA; Gupta N; Idrees MT; Grignon DJ
Am J Surg Pathol; 2019 Aug; 43(8):1099-1111. PubMed ID: 31135486
[TBL] [Abstract][Full Text] [Related]
4. Unilateral synchronous papillary renal neoplasm with reverse polarity and clear cell renal cell carcinoma: a case report with KRAS and PIK3CA mutations.
Lee HJ; Shin DH; Park JY; Kim SY; Hwang CS; Lee JH; Kim JY; Sol MY; Nam JK
Diagn Pathol; 2020 Oct; 15(1):123. PubMed ID: 33023600
[TBL] [Abstract][Full Text] [Related]
5. Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity.
Al-Obaidy KI; Saleeb RM; Trpkov K; Williamson SR; Sangoi AR; Nassiri M; Hes O; Montironi R; Cimadamore A; Acosta AM; Alruwaii ZI; Alkashash A; Hassan O; Gupta N; Osunkoya AO; Sen JD; Baldrige LA; Sakr WA; Idrees MT; Eble JN; Grignon DJ; Cheng L
Mod Pathol; 2022 Sep; 35(9):1279-1286. PubMed ID: 35152262
[TBL] [Abstract][Full Text] [Related]
6. Frequent KRAS mutations in oncocytic papillary renal neoplasm with inverted nuclei.
Tong K; Zhu W; Fu H; Cao F; Wang S; Zhou W; Liu C; Chen D; Fan S; Hu Z
Histopathology; 2020 Jun; 76(7):1070-1083. PubMed ID: 31997427
[TBL] [Abstract][Full Text] [Related]
7. Papillary Renal Neoplasm With Reverse Polarity: A Clinical, Pathologic, and Molecular Study of 8 Renal Tumors From a Single Institution.
Nova-Camacho LM; Martin-Arruti M; Díaz IR; Panizo-Santos Á
Arch Pathol Lab Med; 2023 Jun; 147(6):692-700. PubMed ID: 36170616
[TBL] [Abstract][Full Text] [Related]
8. Papillary renal neoplasm with reverse polarity: a clinicopathologic study of 43 cases with a focus on the expression of KRAS signaling pathway downstream effectors.
Kim B; Lee S; Moon KC
Hum Pathol; 2023 Dec; 142():1-6. PubMed ID: 37797754
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and molecular characterisation of papillary renal neoplasm with reverse polarity and its renal papillary adenoma analogue.
Chang HY; Hang JF; Wu CY; Lin TP; Chung HJ; Chang YH; Pan CC
Histopathology; 2021 Jun; 78(7):1019-1031. PubMed ID: 33351968
[TBL] [Abstract][Full Text] [Related]
10. Papillary renal neoplasm with reverse polarity-a comparative study with CCPRCC, OPRCC, and PRCC1.
Wang T; Ding X; Huang X; Ye J; Li H; Cao S; Gao Y; Ma X; Huang Q; Wang B
Hum Pathol; 2022 Nov; 129():60-70. PubMed ID: 35977593
[TBL] [Abstract][Full Text] [Related]
11. Papillary renal neoplasm with reverse polarity: A clinicopathological and molecular genetic characterization of 16 cases with expanding the morphologic spectrum and further support for a novel entity.
Shen M; Yin X; Bai Y; Zhang H; Ru G; He X; Teng X; Chen G; Zhao M
Front Oncol; 2022; 12():930296. PubMed ID: 35936734
[TBL] [Abstract][Full Text] [Related]
12. Morphological, immunohistochemical, and genomic analyses of papillary renal neoplasm with reverse polarity.
Kiyozawa D; Kohashi K; Takamatsu D; Yamamoto T; Eto M; Iwasaki T; Motoshita J; Shimokama T; Kinjo M; Oshiro Y; Yonemasu H; Oda Y
Hum Pathol; 2021 Jun; 112():48-58. PubMed ID: 33811832
[TBL] [Abstract][Full Text] [Related]
13. Papillary Renal Neoplasm With Reverse Polarity Is Often Cystic: Report of 7 Cases and Review of 93 Cases in the Literature.
Wei S; Kutikov A; Patchefsky AS; Flieder DB; Talarchek JN; Al-Saleem T; Dulaimi E; Uzzo RG; Testa JR; Pei J
Am J Surg Pathol; 2022 Mar; 46(3):336-343. PubMed ID: 34352808
[TBL] [Abstract][Full Text] [Related]
14. Papillary renal neoplasm with reverse polarity may be a novel renal cell tumor entity with low malignant potential.
Yang T; Kang E; Zhang L; Zhuang J; Li Y; Jiang Y; Wang H; Yu W; Zhang W
Diagn Pathol; 2022 Aug; 17(1):66. PubMed ID: 36002896
[TBL] [Abstract][Full Text] [Related]
15. Ipsilateral synchronous papillary renal neoplasm with reverse polarity and urothelial carcinoma in a renal transplant recipient: a rare case report with molecular analysis and literature review.
Li D; Liu F; Chen Y; Li P; Liu Y; Pang Y
Diagn Pathol; 2023 Nov; 18(1):120. PubMed ID: 37924117
[TBL] [Abstract][Full Text] [Related]
16. Papillary renal neoplasm with reverse polarity with a favorable prognosis should be separated from papillary renal cell carcinoma.
Liu Y; Zhang H; Li X; Wang S; Zhang Y; Zhang X; Xu T; Dong Y; Dong L; Zhou L; Yang X; Wang C
Hum Pathol; 2022 Sep; 127():78-85. PubMed ID: 35724772
[TBL] [Abstract][Full Text] [Related]
17. Papillary Renal Neoplasm With Reverse Polarity: A Clinicopathologic Study of 7 Cases.
Zhou L; Xu J; Wang S; Yang X; Li C; Zhou J; Zhang P; Xu H; Wang C
Int J Surg Pathol; 2020 Oct; 28(7):728-734. PubMed ID: 32403965
[TBL] [Abstract][Full Text] [Related]
18. Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins.
Rohan SM; Xiao Y; Liang Y; Dudas ME; Al-Ahmadie HA; Fine SW; Gopalan A; Reuter VE; Rosenblum MK; Russo P; Tickoo SK
Mod Pathol; 2011 Sep; 24(9):1207-20. PubMed ID: 21602815
[TBL] [Abstract][Full Text] [Related]
19. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
[TBL] [Abstract][Full Text] [Related]
20. "Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity.
Shah RB; Stohr BA; Tu ZJ; Gao Y; Przybycin CG; Nguyen J; Cox RM; Rashid-Kolvear F; Weindel MD; Farkas DH; Trpkov K; McKenney JK
Am J Surg Pathol; 2020 May; 44(5):571-581. PubMed ID: 31850909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]